Baseline characteristics of comparative studies assessing effect of combination therapy for unresectable HCC.

Note:† †: TACE was performed using the drug-eluting beads (DEB) in the study. Other studies were conventional TACE.Abbreviations: BCLC, The Barcelona Clinic Liver Cancer; CPS, Child-Pugh classification; Pts., patients; ST: sorafenib+TACE;DT: DEB-TACE; ECOG, Eastern Cooperative Oncology Group; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, Hepatocellular carcinoma; NA: not available; TACE, transarterial chemoembolization.